APA (7th ed.) Citation

Hussain, M., Tejeda, G. S., & Baillie, G. S. (2025). Posttranslational modifications of phosphodiesterase type 4 enzymes represent novel points for therapeutic targeting. FEBS Journal, 292(23), 6182. https://doi.org/10.1111/febs.70205

Chicago Style (17th ed.) Citation

Hussain, Madihah, Gonzalo S. Tejeda, and George S. Baillie. "Posttranslational Modifications of Phosphodiesterase Type 4 Enzymes Represent Novel Points for Therapeutic Targeting." FEBS Journal 292, no. 23 (2025): 6182. https://doi.org/10.1111/febs.70205.

MLA (9th ed.) Citation

Hussain, Madihah, et al. "Posttranslational Modifications of Phosphodiesterase Type 4 Enzymes Represent Novel Points for Therapeutic Targeting." FEBS Journal, vol. 292, no. 23, 2025, p. 6182, https://doi.org/10.1111/febs.70205.